Free Trial

180 Life Sciences (ATNFW) Competitors

180 Life Sciences logo
$0.0075 0.00 (-11.76%)
(As of 12/20/2024 05:31 PM ET)

ATNFW vs. LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, BTMDW, and BCTXW

Should you be buying 180 Life Sciences stock or one of its competitors? The main competitors of 180 Life Sciences include 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

180 Life Sciences vs.

4D pharma (NASDAQ:LBPSW) and 180 Life Sciences (NASDAQ:ATNFW) are both manufacturing companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, community ranking, valuation, profitability, earnings, institutional ownership, dividends and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
4D pharma$522KN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
4D pharmaN/A N/A N/A
180 Life Sciences N/A N/A N/A

4D pharma and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
4D pharmaN/AN/A
180 Life SciencesN/AN/A

In the previous week, 4D pharma's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
4D pharma Neutral
180 Life Sciences Neutral

Summary

4D pharma beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get 180 Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATNFW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATNFW vs. The Competition

Metric180 Life SciencesBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$164.65M$5.14B$9.08B
Dividend YieldN/A3.64%5.09%4.23%
P/E RatioN/A115.5190.0517.18
Price / SalesN/A18,239.951,117.14116.99
Price / CashN/A12.7543.0437.86
Price / BookN/A8.504.784.78
Net IncomeN/A-$20.67M$120.31M$225.60M
7 Day PerformanceN/A-1.04%-1.92%-1.23%
1 Month PerformanceN/A136.65%11.51%3.36%
1 Year PerformanceN/A137.57%30.61%16.60%

180 Life Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATNFW
180 Life Sciences
N/A$0.01
-11.8%
N/A+25.0%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/A$0.04
-25.7%
N/AN/A$0.00$522,000.000.00N/AGap Down
AEHAW
Aesther Healthcare Acquisition
N/A$0.16
+6.2%
N/A+14.1%$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.03
-42.9%
N/A-89.6%$0.00$40,633.000.0040News Coverage
Positive News
ALVOW
Alvotech
N/A$2.78
+1.1%
N/A+26.4%$0.00$391.87M0.004Gap Up
ALVO
Alvotech
2.6568 of 5 stars
$12.10
+2.5%
$18.00
+48.8%
+8.7%$0.00$93.38M0.001,026
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.06
+50.0%
N/A+146.3%$0.00N/A0.004High Trading Volume
ACABU
Atlantic Coastal Acquisition Corp. II
N/A$8.05
-26.8%
N/AN/A$0.00N/A0.004Gap Down
BFRIW
Biofrontera
N/A$0.09
-0.1%
N/A+340.0%$0.00$35.36M0.0070Positive News
BTMDW
biote
N/A$0.47
flat
N/A-58.0%$0.00$193.06M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.36
-10.7%
N/A-81.1%$0.00N/A0.008

Related Companies and Tools


This page (NASDAQ:ATNFW) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners